Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Reverse Transcriptase | 5 | 2018 | 17 | 1.690 |
Why?
|
| Reverse Transcriptase Inhibitors | 3 | 2018 | 32 | 1.400 |
Why?
|
| Deep Brain Stimulation | 4 | 2025 | 446 | 1.370 |
Why?
|
| Triazoles | 4 | 2017 | 141 | 1.040 |
Why?
|
| Molecular Docking Simulation | 6 | 2018 | 161 | 0.790 |
Why?
|
| HIV-1 | 2 | 2018 | 490 | 0.740 |
Why?
|
| Parkinson Disease | 3 | 2025 | 735 | 0.670 |
Why?
|
| Essential Tremor | 1 | 2021 | 96 | 0.630 |
Why?
|
| Software | 2 | 2016 | 733 | 0.630 |
Why?
|
| Resorcinols | 1 | 2018 | 7 | 0.580 |
Why?
|
| Catechols | 1 | 2018 | 9 | 0.580 |
Why?
|
| Ethers | 1 | 2018 | 7 | 0.580 |
Why?
|
| Ligands | 2 | 2016 | 481 | 0.540 |
Why?
|
| Mental Disorders | 1 | 2025 | 910 | 0.510 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 345 | 0.450 |
Why?
|
| Mass Spectrometry | 4 | 2018 | 357 | 0.360 |
Why?
|
| Proteins | 1 | 2016 | 1006 | 0.340 |
Why?
|
| Isotopes | 3 | 2018 | 24 | 0.270 |
Why?
|
| Molecular Structure | 3 | 2018 | 315 | 0.270 |
Why?
|
| Structure-Activity Relationship | 3 | 2018 | 552 | 0.260 |
Why?
|
| Charadriiformes | 2 | 2015 | 2 | 0.230 |
Why?
|
| Mercury | 2 | 2015 | 31 | 0.220 |
Why?
|
| Automation | 1 | 2025 | 65 | 0.220 |
Why?
|
| Enzyme Inhibitors | 2 | 2017 | 573 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2025 | 128 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1618 | 0.200 |
Why?
|
| Monitoring, Physiologic | 1 | 2025 | 376 | 0.190 |
Why?
|
| Electrodes | 1 | 2021 | 82 | 0.170 |
Why?
|
| Nitrogen Isotopes | 2 | 2016 | 45 | 0.150 |
Why?
|
| Carbon Isotopes | 2 | 2016 | 227 | 0.150 |
Why?
|
| Solubility | 1 | 2018 | 117 | 0.140 |
Why?
|
| Wine | 1 | 2018 | 15 | 0.140 |
Why?
|
| Food Contamination | 1 | 2018 | 26 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2018 | 859 | 0.140 |
Why?
|
| Oxygen Isotopes | 1 | 2017 | 34 | 0.130 |
Why?
|
| Drug Design | 1 | 2018 | 156 | 0.130 |
Why?
|
| Models, Chemical | 1 | 2017 | 78 | 0.130 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2017 | 85 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 260 | 0.130 |
Why?
|
| Aconitine | 1 | 2016 | 8 | 0.130 |
Why?
|
| Fullerenes | 1 | 2016 | 4 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2017 | 674 | 0.130 |
Why?
|
| Bridged-Ring Compounds | 1 | 2016 | 19 | 0.130 |
Why?
|
| Hexokinase | 1 | 2016 | 21 | 0.130 |
Why?
|
| Coordination Complexes | 1 | 2016 | 9 | 0.130 |
Why?
|
| Carboxylic Acids | 1 | 2016 | 19 | 0.130 |
Why?
|
| Macrocyclic Compounds | 1 | 2016 | 14 | 0.130 |
Why?
|
| Molecular Conformation | 1 | 2016 | 96 | 0.120 |
Why?
|
| Databases, Protein | 1 | 2016 | 63 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2016 | 118 | 0.110 |
Why?
|
| Imidazoles | 1 | 2016 | 219 | 0.110 |
Why?
|
| Surface Plasmon Resonance | 1 | 2015 | 54 | 0.110 |
Why?
|
| Ovum | 1 | 2015 | 14 | 0.110 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 99 | 0.110 |
Why?
|
| Algorithms | 2 | 2025 | 1680 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2904 | 0.110 |
Why?
|
| Water Pollutants, Chemical | 1 | 2015 | 37 | 0.110 |
Why?
|
| Protein Binding | 2 | 2017 | 1652 | 0.100 |
Why?
|
| Hepatoblastoma | 1 | 2016 | 204 | 0.100 |
Why?
|
| Thermodynamics | 1 | 2013 | 147 | 0.100 |
Why?
|
| Catalytic Domain | 1 | 2013 | 161 | 0.100 |
Why?
|
| Rhabdomyosarcoma | 1 | 2015 | 231 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 421 | 0.090 |
Why?
|
| Nanomedicine | 1 | 2012 | 33 | 0.090 |
Why?
|
| Copper | 1 | 2012 | 69 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2013 | 179 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 110 | 0.090 |
Why?
|
| Humans | 11 | 2025 | 131163 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 152 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 292 | 0.080 |
Why?
|
| Biomarkers | 1 | 2016 | 3385 | 0.060 |
Why?
|
| Poland | 2 | 2018 | 18 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1373 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1336 | 0.050 |
Why?
|
| Binding Sites | 2 | 2017 | 1133 | 0.050 |
Why?
|
| Movement | 1 | 2025 | 147 | 0.050 |
Why?
|
| Neoplasms | 2 | 2015 | 3016 | 0.050 |
Why?
|
| Ecosystem | 1 | 2023 | 91 | 0.050 |
Why?
|
| Video Recording | 1 | 2023 | 193 | 0.040 |
Why?
|
| Data Collection | 1 | 2023 | 370 | 0.040 |
Why?
|
| Machine Learning | 1 | 2025 | 387 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2016 | 15110 | 0.040 |
Why?
|
| Candida parapsilosis | 1 | 2017 | 3 | 0.030 |
Why?
|
| Male | 6 | 2025 | 64957 | 0.030 |
Why?
|
| Staphylococcus epidermidis | 1 | 2017 | 39 | 0.030 |
Why?
|
| Candida albicans | 1 | 2017 | 88 | 0.030 |
Why?
|
| Benzophenones | 1 | 2016 | 7 | 0.030 |
Why?
|
| Animals | 5 | 2016 | 33912 | 0.030 |
Why?
|
| Kidney Cortex | 1 | 2016 | 19 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 46 | 0.030 |
Why?
|
| Female | 6 | 2025 | 70963 | 0.030 |
Why?
|
| Infant | 3 | 2016 | 13352 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2017 | 155 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 274 | 0.030 |
Why?
|
| Humidity | 1 | 2015 | 26 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2015 | 94 | 0.030 |
Why?
|
| Child | 4 | 2016 | 26341 | 0.030 |
Why?
|
| Muscles | 1 | 2015 | 197 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2016 | 716 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2017 | 292 | 0.030 |
Why?
|
| Rivers | 1 | 2015 | 12 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 1088 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 470 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 394 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 1064 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 521 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2016 | 8635 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1287 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 953 | 0.020 |
Why?
|
| Mitochondria | 1 | 2016 | 785 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2200 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1827 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3359 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3748 | 0.020 |
Why?
|
| Diet | 1 | 2015 | 1121 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1796 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 4886 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21025 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2596 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 28601 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 3175 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 18301 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 20987 | 0.010 |
Why?
|